159 related articles for article (PubMed ID: 2165199)
1. Human urinary excretion profile after smoking and oral administration of [14C]delta 1-tetrahydrocannabinol.
Johansson E; Gillespie HK; Halldin MM
J Anal Toxicol; 1990; 14(3):176-80. PubMed ID: 2165199
[TBL] [Abstract][Full Text] [Related]
2. Urinary excretion half-life of delta 1-tetrahydrocannabinol-7-oic acid in heavy marijuana users after smoking.
Johansson E; Halldin MM
J Anal Toxicol; 1989; 13(4):218-23. PubMed ID: 2550702
[TBL] [Abstract][Full Text] [Related]
3. Urinary elimination half-life of delta-1-tetrahydrocannabinol-7-oic acid in heavy marijuana users after smoking.
Johansson EK; Hollister LE; Halldin MM
NIDA Res Monogr; 1989; 95():457-8. PubMed ID: 2561839
[TBL] [Abstract][Full Text] [Related]
4. Urinary excretion profiles of 11-nor-9-carboxy-Delta9-tetrahydrocannabinol: a Delta9-THC-COOH to creatinine ratio study #2.
Fraser AD; Worth D
Forensic Sci Int; 2003 Apr; 133(1-2):26-31. PubMed ID: 12742686
[TBL] [Abstract][Full Text] [Related]
5. Urinary excretion profiles of 11-nor-9-carboxy-delta 9-tetrahydrocannabinol in humans after single smoked doses of marijuana.
Huestis MA; Mitchell JM; Cone EJ
J Anal Toxicol; 1996 Oct; 20(6):441-52. PubMed ID: 8889681
[TBL] [Abstract][Full Text] [Related]
6. Terminal elimination plasma half-life of delta 1-tetrahydrocannabinol (delta 1-THC) in heavy users of marijuana.
Johansson E; Halldin MM; Agurell S; Hollister LE; Gillespie HK
Eur J Clin Pharmacol; 1989; 37(3):273-7. PubMed ID: 2558889
[TBL] [Abstract][Full Text] [Related]
7. Urinary excretion profiles of 11-nor-9-carboxy-Delta9-tetrahydrocannabinol. Study III. A Delta9-THC-COOH to creatinine ratio study.
Fraser AD; Worth D
Forensic Sci Int; 2003 Nov; 137(2-3):196-202. PubMed ID: 14609657
[TBL] [Abstract][Full Text] [Related]
8. Marijuana metabolites in urine of man. X. Identification of marijuana use by detection of delta 9-tetrahydrocannabinol-11-oic acid using thin-layer chromatography.
Kanter SL; Hollister LE; Musumeci M
J Chromatogr; 1982 Jan; 234(1):201-8. PubMed ID: 6276425
[TBL] [Abstract][Full Text] [Related]
9. Combination of liquid chromatography with ultraviolet detection and gas chromatography with electron-capture detection for the determination of delta 9-tetrahydrocannabinol-11-oic acid in urine.
Karlsson L; Roos C
J Chromatogr; 1984 Mar; 306():183-9. PubMed ID: 6325483
[TBL] [Abstract][Full Text] [Related]
10. Urinary pharmacokinetics of 11-nor-9-carboxy-delta9-tetrahydrocannabinol after controlled oral delta9-tetrahydrocannabinol administration.
Gustafson RA; Kim I; Stout PR; Klette KL; George MP; Moolchan ET; Levine B; Huestis MA
J Anal Toxicol; 2004 Apr; 28(3):160-7. PubMed ID: 15107145
[TBL] [Abstract][Full Text] [Related]
11. Forensic aspects of the metabolism and excretion of cannabinoids following oral ingestion of cannabis resin.
Law B; Mason PA; Moffat AC; Gleadle RI; King LJ
J Pharm Pharmacol; 1984 May; 36(5):289-94. PubMed ID: 6145762
[TBL] [Abstract][Full Text] [Related]
12. Plasma and urine profiles of Delta9-tetrahydrocannabinol and its metabolites 11-hydroxy-Delta9-tetrahydrocannabinol and 11-nor-9-carboxy-Delta9-tetrahydrocannabinol after cannabis smoking by male volunteers to estimate recent consumption by athletes.
Brenneisen R; Meyer P; Chtioui H; Saugy M; Kamber M
Anal Bioanal Chem; 2010 Apr; 396(7):2493-502. PubMed ID: 20112012
[TBL] [Abstract][Full Text] [Related]
13. Temporal indication of cannabis use by means of THC glucuronide determination.
Mareck U; Haenelt N; Geyer H; Guddat S; Kamber M; Brenneisen R; Thevis M; Schänzer W
Drug Test Anal; 2009 Nov; 1(11-12):505-10. PubMed ID: 20355165
[TBL] [Abstract][Full Text] [Related]
14. GC/MS and EMIT analyses for delta 9-tetrahydrocannabinol metabolites in plasma and urine of human subjects.
McBurney LJ; Bobbie BA; Sepp LA
J Anal Toxicol; 1986; 10(2):56-64. PubMed ID: 3009969
[TBL] [Abstract][Full Text] [Related]
15. Detection times of marijuana metabolites in urine by immunoassay and GC-MS.
Huestis MA; Mitchell JM; Cone EJ
J Anal Toxicol; 1995 Oct; 19(6):443-9. PubMed ID: 8926739
[TBL] [Abstract][Full Text] [Related]
16. Passive inhalation of marijuana smoke: urinalysis and room air levels of delta-9-tetrahydrocannabinol.
Cone EJ; Johnson RE; Darwin WD; Yousefnejad D; Mell LD; Paul BD; Mitchell J
J Anal Toxicol; 1987; 11(3):89-96. PubMed ID: 3037193
[TBL] [Abstract][Full Text] [Related]
17. Screening for cannabinoids in blood using EMIT: concentrations of delta-9-tetrahydrocannabinol in relation to EMIT results.
Gjerde H
Forensic Sci Int; 1991; 50(1):121-4. PubMed ID: 1657743
[TBL] [Abstract][Full Text] [Related]
18. Elimination of 11-nor-9-carboxy-delta-9-tetrahydrocannabinol when normalized to urinary creatinine.
Beardsley GD; Christensen JM
Res Commun Mol Pathol Pharmacol; 2007-2008; 120-121(1-6):67-78. PubMed ID: 21469505
[TBL] [Abstract][Full Text] [Related]
19. Short communication: Urinary excretion of 11-nor-9-carboxy-Delta(9)-tetrahydrocannabinol in a pregnant woman following heavy, chronic cannabis use.
Westin AA; Huestis MA; Aarstad K; Spigset O
J Anal Toxicol; 2009; 33(9):610-4. PubMed ID: 20040136
[TBL] [Abstract][Full Text] [Related]
20. Confirmation of cannabis use. II. Determination of tetrahydrocannabinol metabolites in urine and plasma by HPLC with ECD.
Nakahara Y; Sekine H; Cook CE
J Anal Toxicol; 1989; 13(1):22-4. PubMed ID: 2540383
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
